stoxline Quote Chart Rank Option Currency Glossary
  
Thermo Fisher Scientific Inc. (TMO)
568  -4.05 (-0.71%)    06-17 16:00
Open: 566.45
High: 569.305
Volume: 1,005,958
  
Pre. Close: 572.05
Low: 563.745
Market Cap: 216,815(M)
Technical analysis
2024-06-17 5:26:55 PM
Short term     
Mid term     
Targets 6-month :  680.08 1-year :  703.13
Resists First :  582.26 Second :  602
Pivot price 572.78
Supports First :  550.33 Second :  457.87
MAs MA(5) :  572.85 MA(20) :  576.79
MA(100) :  571.65 MA(250) :  536.26
MACD MACD :  -1.7 Signal :  -0.8
%K %D K(14,3) :  53.6 D(3) :  54.4
RSI RSI(14): 40.7
52-week High :  603.82 Low :  415.6
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ TMO ] has closed above bottom band by 27.3%. Bollinger Bands are 44.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 573.02 - 578.52 578.52 - 581.85
Low: 551.83 - 559.16 559.16 - 563.59
Close: 559.63 - 571.51 571.51 - 578.7
Company Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Headline News

Mon, 17 Jun 2024
Trust Co. of Vermont Has $20.27 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - Defense World

Mon, 17 Jun 2024
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Brown Shipley& Co Ltd - Defense World

Mon, 17 Jun 2024
Fisher Asset Management LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - Defense World

Mon, 17 Jun 2024
40000 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Acquired by PBCay One RSC Ltd - Defense World

Mon, 17 Jun 2024
4998 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Processus Wealth & Capital Management LLC - Defense World

Mon, 17 Jun 2024
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Wellington Management Group LLP - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 382 (M)
Shares Float 381 (M)
Held by Insiders 0.1 (%)
Held by Institutions 90.7 (%)
Shares Short 2,800 (K)
Shares Short P.Month 2,590 (K)
Stock Financials
EPS 15.56
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 119.23
Profit Margin 14.1 %
Operating Margin 16.6 %
Return on Assets (ttm) 4.8 %
Return on Equity (ttm) 13.6 %
Qtrly Rev. Growth -3.5 %
Gross Profit (p.s.) 0
Sales Per Share 111.31
EBITDA (p.s.) 28.24
Qtrly Earnings Growth 4.1 %
Operating Cash Flow 8,930 (M)
Levered Free Cash Flow 6,070 (M)
Stock Valuations
PE Ratio 36.48
PEG Ratio 3.9
Price to Book value 4.76
Price to Sales 5.1
Price to Cash Flow 24.27
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android